PLRX
Pliant Therapeutics Inc
NASDAQ: PLRX · HEALTHCARE · BIOTECHNOLOGY
$1.21
+0.00% today
Updated 2026-04-29
Market cap
$74.92M
P/E ratio
—
P/S ratio
3,071.82x
EPS (TTM)
$-2.43
Dividend yield
—
52W range
$1 – $2
Volume
0.6M
Pliant Therapeutics Inc (PLRX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-61.60%
ROA
-30.10%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2017 | — | $-20.62M | — | — | — |
| 2018 | $0.00 | $-30.28M | — | — | — |
| 2019 | $57.05M | $-631000.00 | 100.00% | -2.16% | -1.11% |
| 2020 | $41.82M | $-39.74M | 100.00% | -99.59% | -95.05% |
| 2021 | $7.57M | $-17.91M | 100.00% | -263.95% | -236.49% |
| 2022 | $9.69M | $-123.32M | 100.00% | -1,313.37% | -1,273.32% |
| 2023 | $1.58M | $-161.34M | 100.00% | -11,654.75% | -10,211.14% |
| 2024 | $0.00 | $-210.30M | — | — | — |
| 2025 | $0.00 | $-149.34M | — | — | — |